article thumbnail

Senate Dems reach draft deal to extend ACA premiums, lower drug costs

Healthcare Dive

The bill, part of a more than $300 billion package, extends enhanced ACA premiums and allows Medicare to negotiate select prescription drug prices starting in 2026.

ACA 264
article thumbnail

Medicare Prescription Payment Plan (M3P) Implementation: Key Considerations for Part D Plan Sponsors and PBMs

Innovaare Compliance

These requirements include: Detailed Reporting: Plans must submit comprehensive data on prescription drug pricing, utilization, and patient outcomes. Price Transparency: Increased transparency in drug pricing to enable beneficiaries to make informed decisions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medicare Prescription Payment Plan (M3P) Implementation: Key Considerations for Part D Plan Sponsors and PBMs

Innovaare Compliance

These requirements include: Detailed Reporting: Plans must submit comprehensive data on prescription drug pricing, utilization, and patient outcomes. Price Transparency: Increased transparency in drug pricing to enable beneficiaries to make informed decisions.

article thumbnail

CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs

Healthcare Law Blog

All rebate payments will be deposited into the Medicare Prescription Drug Account in the Federal Supplementary Medical Insurance Trust Fund. 10] This allows CMS to identify drugs and biologics that are already discounted under the 340B Drug Pricing Program for its inflation rebate calculation. [11] 17-921 (Aug.

article thumbnail

Health Provider News

Hall Render

Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass. Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’

article thumbnail

Democrats Didn’t Achieve All Their Goals, but Inflation Reduction Act Makes Historic Medicare Changes

Kaiser Health News

Never before have we been able to negotiate prescription drug prices. Department of Health and Human Services to identify Medicare’s 100 most expensive drugs and then pick 10 for price negotiations starting in 2023. Those prices would take effect in 2026. “It’s historic.

article thumbnail

Regulating the Medication Gatekeepers: The Need for Federal PBM Reform

Bill of Health

Conclusion PBMs hold significant power over prescription drug pricing and access. 2026), whose research interests include innovative medical technologies and chronic disease policy. Rupa Palanki is a law student (J.D.